After adjusting for other prognostic factors (age, stage, grade and tumor residual size), low MGRN1 expression was also significantly associated with shorter OS (Table 1, P=0.01), demonstrating that MGRN1 expression was an independent predictor of poorer clinical outcomes in HGSOC patients. The gene discussed is MGRN1; the disease is neoplasm.